State-of-the-art management of nasopharyngeal carcinoma: current and future directions

Nasopharyngeal carcinoma (NPC) is a distinct type of head and neck cancer. Approximately 70% of patients with newly diagnosed NPC present with locally advanced disease. Phase III clinical trials support the addition of chemotherapy to radiotherapy for the initial treatment of these patients. Once me...

Descripción completa

Detalles Bibliográficos
Autores principales: Agulnik, M, Siu, L L
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361911/
https://www.ncbi.nlm.nih.gov/pubmed/15756250
http://dx.doi.org/10.1038/sj.bjc.6602449
_version_ 1782153331346505728
author Agulnik, M
Siu, L L
author_facet Agulnik, M
Siu, L L
author_sort Agulnik, M
collection PubMed
description Nasopharyngeal carcinoma (NPC) is a distinct type of head and neck cancer. Approximately 70% of patients with newly diagnosed NPC present with locally advanced disease. Phase III clinical trials support the addition of chemotherapy to radiotherapy for the initial treatment of these patients. Once metastatic disease develops, practices become varied. Further experience needs to be gained with both targeted therapies and immunotherapy to gauge whether they will improve treatment outcomes in NPC.
format Text
id pubmed-2361911
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23619112009-09-10 State-of-the-art management of nasopharyngeal carcinoma: current and future directions Agulnik, M Siu, L L Br J Cancer Minireview Nasopharyngeal carcinoma (NPC) is a distinct type of head and neck cancer. Approximately 70% of patients with newly diagnosed NPC present with locally advanced disease. Phase III clinical trials support the addition of chemotherapy to radiotherapy for the initial treatment of these patients. Once metastatic disease develops, practices become varied. Further experience needs to be gained with both targeted therapies and immunotherapy to gauge whether they will improve treatment outcomes in NPC. Nature Publishing Group 2005-03-14 2005-03-01 /pmc/articles/PMC2361911/ /pubmed/15756250 http://dx.doi.org/10.1038/sj.bjc.6602449 Text en Copyright © 2005 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Minireview
Agulnik, M
Siu, L L
State-of-the-art management of nasopharyngeal carcinoma: current and future directions
title State-of-the-art management of nasopharyngeal carcinoma: current and future directions
title_full State-of-the-art management of nasopharyngeal carcinoma: current and future directions
title_fullStr State-of-the-art management of nasopharyngeal carcinoma: current and future directions
title_full_unstemmed State-of-the-art management of nasopharyngeal carcinoma: current and future directions
title_short State-of-the-art management of nasopharyngeal carcinoma: current and future directions
title_sort state-of-the-art management of nasopharyngeal carcinoma: current and future directions
topic Minireview
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361911/
https://www.ncbi.nlm.nih.gov/pubmed/15756250
http://dx.doi.org/10.1038/sj.bjc.6602449
work_keys_str_mv AT agulnikm stateoftheartmanagementofnasopharyngealcarcinomacurrentandfuturedirections
AT siull stateoftheartmanagementofnasopharyngealcarcinomacurrentandfuturedirections

Ejemplares similares